As compared with the ACC group, the levels of EPO (AST, FRM group), TPO (AST, FRM group), and GM-CSF (FRA, AST, FRM, CLG group) were decreased in serum, yet there was no difference in the other groups. This evidence concerns the gene EPO and adrenal cortex carcinoma.